{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:35:17Z","timestamp":1787160917129,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270958"],"award-info":[{"award-number":["32270958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525030"],"award-info":[{"award-number":["82525030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92474110"],"award-info":[{"award-number":["92474110"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003008"],"award-info":[{"award-number":["82003008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41590-026-02510-w","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:08:16Z","timestamp":1777453696000},"page":"1253-1267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kupffer cell calibration of T cell responses via VSIG4\u2013CD5 interaction promotes tumor evasion"],"prefix":"10.1038","volume":"27","author":[{"given":"Xia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0024-1096","authenticated-orcid":false,"given":"Chaowei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-7558","authenticated-orcid":false,"given":"Ao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-7664","authenticated-orcid":false,"given":"Zhutian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2510_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151\u2013167 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2510_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li, X. et al. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat. Rev. Cancer 21, 541\u2013557 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2510_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras, D. I. et al. Liver metastases. Nat. Rev. Dis. Primers 7, 27 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2510_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu, J. et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat. Med. 27, 152\u2013164 (2021).","journal-title":"Nat. Med."},{"key":"2510_CR5","doi-asserted-by":"publisher","first-page":"e2118416","DOI":"10.1001\/jamanetworkopen.2021.18416","volume":"4","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Clinical response to immunotherapy targeting programmed cell death receptor 1\/programmed cell death ligand 1 in patients with treatment-resistant microsatellite stable colorectal cancer with and without liver metastases. JAMA Netw. Open 4, e2118416 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2510_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.chom.2016.06.002","volume":"20","author":"Z Zeng","year":"2016","unstructured":"Zeng, Z. et al. CRIg functions as a macrophage pattern recognition receptor to directly bind and capture blood-borne Gram-positive bacteria. Cell Host Microbe 20, 99\u2013106 (2016).","journal-title":"Cell Host Microbe"},{"key":"2510_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-018-0211-2","volume":"19","author":"Z Zeng","year":"2018","unstructured":"Zeng, Z. et al. Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. Nat. Immunol. 19, 1100\u20131111 (2018).","journal-title":"Nat. Immunol."},{"key":"2510_CR8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41590-023-01634-7","volume":"24","author":"J Li","year":"2023","unstructured":"Li, J. et al. The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. Nat. Immunol. 24, 1813\u20131824 (2023).","journal-title":"Nat. Immunol."},{"key":"2510_CR9","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","volume":"113","author":"Y Kimura","year":"2016","unstructured":"Kimura, Y. et al. The innate immune receptor dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc. Natl Acad. of Sci. USA 113, 14097\u201314102 (2016).","journal-title":"Proc. Natl Acad. of Sci. USA"},{"key":"2510_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2015.08.013","volume":"43","author":"J Dupaul-Chicoine","year":"2015","unstructured":"Dupaul-Chicoine, J. et al. The NLRP3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity. Immunity 43, 751\u2013763 (2015).","journal-title":"Immunity"},{"key":"2510_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41586-023-06950-4","volume":"626","author":"Z Deng","year":"2024","unstructured":"Deng, Z. et al. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature 626, 864\u2013873 (2024).","journal-title":"Nature"},{"key":"2510_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson, A. W. & Knolle, P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 10, 753\u2013766 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"2510_CR13","doi-asserted-by":"publisher","first-page":"938470","DOI":"10.3389\/fimmu.2022.938470","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Khan, S., Huang, D. & Li, L. V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front. Immunol. 13, 938470 (2022).","journal-title":"Front. Immunol."},{"key":"2510_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","volume":"124","author":"KY Helmy","year":"2006","unstructured":"Helmy, K. Y. et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915\u2013927 (2006).","journal-title":"Cell"},{"key":"2510_CR15","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1172\/JCI25673","volume":"116","author":"L Vogt","year":"2006","unstructured":"Vogt, L. et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 116, 2817\u20132826 (2006).","journal-title":"J. Clin. Invest."},{"key":"2510_CR16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29540","volume":"6","author":"X Yuan","year":"2017","unstructured":"Yuan, X., Yang, B.-H., Dong, Y., Yamamura, A. & Fu, W. CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells. eLife 6, e29540 (2017).","journal-title":"eLife"},{"key":"2510_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbrc.2022.04.120","volume":"614","author":"A Widyagarini","year":"2022","unstructured":"Widyagarini, A., Nishii, N., Kawano, Y., Zhang, C. & Azuma, M. VSIG4\/CRIg directly regulates early CD8+ T cell activation through its counter-receptor in a narrow window. Biochem. Biophys. Res. Commun. 614, 100\u2013106 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2510_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215996","volume":"553","author":"B Liu","year":"2023","unstructured":"Liu, B. et al. The biology of VSIG4: implications for the treatment of immune-mediated inflammatory diseases and cancer. Cancer Lett. 553, 215996 (2023).","journal-title":"Cancer Lett."},{"key":"2510_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bbrc.2022.08.055","volume":"628","author":"K Jung","year":"2022","unstructured":"Jung, K. et al. VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity. Biochem. Biophys. Res. Commun. 628, 18\u201324 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2510_CR20","doi-asserted-by":"crossref","unstructured":"Liu, W. et al. In situ expansion and reprogramming of Kupffer cells elicit potent tumoricidal immunity against liver metastasis. J. Clin. Invest. 133, e157937 (2023).","DOI":"10.1172\/JCI157937"},{"key":"2510_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","volume":"574","author":"AP Benechet","year":"2019","unstructured":"Benechet, A. P. et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature 574, 200\u2013205 (2019).","journal-title":"Nature"},{"key":"2510_CR22","doi-asserted-by":"crossref","unstructured":"You, Q., Cheng, L., Kedl, R.M. & Ju, C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 48, 978\u2013990 (2008).","DOI":"10.1002\/hep.22395"},{"key":"2510_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey, C. et al. Cross-priming in cancer immunology and immunotherapy. Nat. Rev. Cancer 25, 249\u2013273 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"2510_CR24","doi-asserted-by":"crossref","unstructured":"Hildner, K. et al. BATF3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097\u20131100 (2008).","DOI":"10.1126\/science.1164206"},{"key":"2510_CR25","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.4049\/jimmunol.1001360","volume":"185","author":"LA Albacker","year":"2010","unstructured":"Albacker, L. A. et al. TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells. J. Immunol. 185, 6839\u20136849 (2010).","journal-title":"J. Immunol."},{"key":"2510_CR26","doi-asserted-by":"publisher","first-page":"TPS2693","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS2693","volume":"40","author":"AW Tolcher","year":"2022","unstructured":"Tolcher, A. W. et al. A phase 1\/2 dose escalation\/expansion study of OR2805 alone or in combination in subjects with advanced solid tumors. J. Clin. Oncol. 40, TPS2693 (2022).","journal-title":"J. Clin. Oncol."},{"key":"2510_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01327-4","volume":"8","author":"J Li","year":"2017","unstructured":"Li, J. et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat. Commun. 8, 1322 (2017).","journal-title":"Nat. Commun."},{"key":"2510_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau7426","volume":"5","author":"X Huang","year":"2019","unstructured":"Huang, X. et al. VSIG4 mediates transcriptional inhibition of NLRP3 and IL-1\u03b2 in macrophages. Sci. Adv. 5, eaau7426 (2019).","journal-title":"Sci. Adv."},{"key":"2510_CR29","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.3389\/fimmu.2018.02900","volume":"9","author":"G Voisinne","year":"2018","unstructured":"Voisinne, G., Gonzalez de Peredo, A. & Roncagalli, R. CD5, an undercover regulator of TCR signaling. Front. Immunol. 9, 2900 (2018).","journal-title":"Front. Immunol."},{"key":"2510_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/eji.201948309","volume":"50","author":"F Alotaibi","year":"2020","unstructured":"Alotaibi, F. et al. CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity. Eur. J. Immunol. 50, 695\u2013704 (2020).","journal-title":"Eur. J. Immunol."},{"key":"2510_CR31","doi-asserted-by":"crossref","unstructured":"Friedlein, G. et al. Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J. Immunol. 178, 6821\u20136827 (2007).","DOI":"10.4049\/jimmunol.178.11.6821"},{"key":"2510_CR32","doi-asserted-by":"publisher","first-page":"876","DOI":"10.15252\/msb.20166837","volume":"12","author":"G Voisinne","year":"2016","unstructured":"Voisinne, G. et al. Co-recruitment analysis of the Cbl and Cbl-b signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation. Mol. Syst. Biol. 12, 876 (2016).","journal-title":"Mol. Syst. Biol."},{"key":"2510_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/35067100","volume":"2","author":"CBF Thien","year":"2001","unstructured":"Thien, C. B. F. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2, 294\u2013307 (2001).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2510_CR34","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.immuni.2023.11.010","volume":"56","author":"Y-L Tsai","year":"2023","unstructured":"Tsai, Y.-L. et al. TCR signaling promotes formation of an STS1\u2013Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments. Immunity 56, 2682\u20132698 (2023).","journal-title":"Immunity"},{"key":"2510_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41590-021-00888-3","volume":"22","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity. Nat. Immunol. 22, 460\u2013470 (2021).","journal-title":"Nat. Immunol."},{"key":"2510_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1074-7613(01)00173-X","volume":"15","author":"C Rosette","year":"2001","unstructured":"Rosette, C. et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15, 59\u201370 (2001).","journal-title":"Immunity"},{"key":"2510_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"2510_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 (2020).","journal-title":"Immunity"},{"key":"2510_CR39","doi-asserted-by":"publisher","first-page":"158ra145","DOI":"10.1126\/scitranslmed.3004394","volume":"4","author":"L Ritsma","year":"2012","unstructured":"Ritsma, L. et al. Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci. Transl. Med 4, 158ra145 (2012).","journal-title":"Sci. Transl. Med"},{"key":"2510_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"2510_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572\u2013576 (2014).","journal-title":"Nature"},{"key":"2510_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110609","volume":"39","author":"S Li","year":"2022","unstructured":"Li, S. et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 39, 110609 (2022).","journal-title":"Cell Rep."},{"key":"2510_CR43","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","volume":"54","author":"G De Simone","year":"2021","unstructured":"De Simone, G. et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity 54, 2089\u20132100 (2021).","journal-title":"Immunity"},{"key":"2510_CR44","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s41590-025-02199-3","volume":"26","author":"V Venzin","year":"2025","unstructured":"Venzin, V. et al. CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming. Nat. Immunol. 26, 1352\u20131366 (2025).","journal-title":"Nat. Immunol."},{"key":"2510_CR45","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ccell.2023.09.014","volume":"41","author":"T Kerzel","year":"2023","unstructured":"Kerzel, T. et al. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases. Cancer Cell 41, 1892\u20131910 (2023).","journal-title":"Cancer Cell"},{"key":"2510_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41771-z","volume":"14","author":"SK Thomas","year":"2023","unstructured":"Thomas, S. K. et al. Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice. Nat. Commun. 14, 6330 (2023).","journal-title":"Nat. Commun."},{"key":"2510_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504929","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen, C. et al. Viral-directed augmentation of Kupffer cell cross-presentation provokes antitumor immunity against liver metastasis. Adv. Sci. 12, e04929 (2025).","journal-title":"Adv. Sci."},{"key":"2510_CR48","doi-asserted-by":"crossref","unstructured":"Heymann, F. et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 62, 279\u2013291 (2015).","DOI":"10.1002\/hep.27793"},{"key":"2510_CR49","doi-asserted-by":"publisher","first-page":"12969","DOI":"10.1073\/pnas.1917182117","volume":"117","author":"G Blaize","year":"2020","unstructured":"Blaize, G. et al. CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens. Proc. Natl Acad. Sci. USA 117, 12969\u201312979 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2510_CR50","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.4049\/jimmunol.170.9.4623","volume":"170","author":"CD Brossard","year":"2003","unstructured":"Brossard, C. D., Semichon, M., Trautmann, A. & Bismuth, G. CD5 inhibits signaling at the immunological synapse without impairing its formation. J. Immunol. 170, 4623\u20134629 (2003).","journal-title":"J. Immunol."},{"key":"2510_CR51","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/glycob\/cwad050","volume":"33","author":"SY Ebstein","year":"2023","unstructured":"Ebstein, S. Y. et al. VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding. Glycobiology 33, 591\u2013604 (2023).","journal-title":"Glycobiology"},{"key":"2510_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1432-1327.1998.2570131.x","volume":"257","author":"MSB McAlister","year":"1998","unstructured":"McAlister, M. S. B. et al. Structural analysis of the CD5 antigen\u2014expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1. Eur. J. Biochem. 257, 131\u2013141 (1998).","journal-title":"Eur. J. Biochem."},{"key":"2510_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1574-6968.2002.tb11039.x","volume":"207","author":"MC Jendro","year":"2002","unstructured":"Jendro, M. C., K\u00f6hler, L., Kuipers, J. G. & Zeidler, H. Microbe-induced T cell apoptosis: subversion of the host defense system? FEMS Microbiol. Lett. 207, 121\u2013126 (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"2510_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cas.15173","volume":"113","author":"I Hoshino","year":"2022","unstructured":"Hoshino, I. et al. Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics. Cancer Sci. 113, 229\u2013239 (2022).","journal-title":"Cancer Sci."},{"key":"2510_CR55","doi-asserted-by":"crossref","unstructured":"Xia, H. et al. Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis. JCI Insight 5, e141115 (2020).","DOI":"10.1172\/jci.insight.141115"},{"key":"2510_CR56","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ccell.2021.05.006","volume":"39","author":"A Chow","year":"2021","unstructured":"Chow, A. et al. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. Cancer Cell 39, 973\u2013988 (2021).","journal-title":"Cancer Cell"},{"key":"2510_CR57","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.3390\/ijms25116160","volume":"25","author":"S Sazinsky","year":"2024","unstructured":"Sazinsky, S. et al. Antibodies targeting human or mouse VSIG4 repolarize tumor-associated macrophages providing the potential of potent and specific clinical anti-tumor response induced across multiple cancer types. Int. J. Mol. Sci. 25, 6160 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2510_CR58","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1016\/j.devcel.2025.04.011","volume":"60","author":"Z Ma","year":"2025","unstructured":"Ma, Z. et al. Targeting VSIG4+ tissue-resident macrophages enhances T cell cytotoxicity and immunotherapy efficacy in cancer. Dev. Cell 60, 2594\u20132610 (2025).","journal-title":"Dev. Cell"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02510-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02510-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02510-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:01:49Z","timestamp":1780351309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02510-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2510"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02510-w","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}